Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 450 of 1475 entries
View as:

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

Phase: N/A Priority: Normal
NCT ID: NCT06357754 Org: User:
Start: 10/06/23 End: 10/06/38 Due: 10/06/39

A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread

Phase: N/A Priority: Normal
NCT ID: NCT03098550 Org: User:
Start: 06/15/17 End: 07/06/20 Due: 07/06/21

Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment

Phase: N/A Priority: Normal
NCT ID: NCT05065762 Org: User:
Start: 10/01/21 End: 02/07/22 Due: 02/07/23

Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00656734 Org: User:
Start: 04/30/08 End: 06/30/10 Due: 06/30/11

Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT01766817 Org: User:
Start: 01/31/13 End: 02/29/16 Due: 02/28/17

A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT02157506 Org: User:
Start: 06/30/14 End: 07/31/15 Due: 07/31/16

Early Post-marketing Study of Daclatasvir (Daklinza) in the Treatment of Chronic Hepatitis C (CHC) in Adults

Phase: N/A Priority: Normal
NCT ID: NCT03181074 Org: User:
Start: 10/21/15 End: 08/19/19 Due: 08/19/20

Study of Nivolumab (BMS-936558) Plus Ipilimumab Compared With Ipilimumab Alone in the Treatment of Previously Untreated, Unresectable, or Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01927419 Org: User:
Start: 08/23/13 End: 02/26/21 Due: 02/26/22

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Phase: N/A Priority: Normal
NCT ID: NCT01714817 Org: User:
Start: 01/22/13 End: 05/30/18 Due: 05/30/19

A Dose-Defining Study of CXL-1020 in Patients With Systolic Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT01096043 Org: User:
Start: 04/30/10 End: 02/29/12 Due: 02/28/13

A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen

Phase: N/A Priority: Normal
NCT ID: NCT00135447 Org: User:
Start: 09/30/04 End: 09/30/09 Due: 09/30/10

Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00455533 Org: User:
Start: 10/31/07 End: 12/31/09 Due: 12/31/10

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Phase: N/A Priority: Normal
NCT ID: NCT06561386 Org: User:
Start: 10/07/24 End: 11/11/33 Due: 11/11/34

A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen

Phase: N/A Priority: Normal
NCT ID: NCT00035633 Org: User:
Start: 12/31/01 End: 02/28/05 Due: 02/28/06

Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Phase: N/A Priority: Normal
NCT ID: NCT00101608 Org: User:
Start: 01/31/05 End: 04/30/07 Due: 04/30/08

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06976216 Org: User:
Start: 07/25/25 End: 02/23/29 Due: 02/23/30

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

Phase: N/A Priority: Normal
NCT ID: NCT06976203 Org: User:
Start: 07/25/25 End: 02/23/29 Due: 02/23/30

A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM

Phase: N/A Priority: Normal
NCT ID: NCT03723655 Org: User:
Start: 09/27/18 End: 01/16/26 Due: 01/16/27

Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00851045 Org: User:
Start: 10/31/09 End: 10/31/11 Due: 10/31/12

Treatment Patterns in Advanced Small Cell Lung Cancer (SCLC)

Phase: N/A Priority: Normal
NCT ID: NCT03425825 Org: User:
Start: 12/15/16 End: 01/24/19 Due: 01/24/20

An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02750514 Org: User:
Start: 05/09/16 End: 01/29/20 Due: 01/29/21

Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen

Phase: N/A Priority: Normal
NCT ID: NCT00002429 Org: User:
Start: 07/31/99 End: 01/31/01 Due: 01/31/02

Drug-Drug Interaction Study With Aricept® (Donepezil)

Phase: N/A Priority: Normal
NCT ID: NCT01042314 Org: User:
Start: 01/31/10 End: 04/30/10 Due: 04/30/11

BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00097357 Org: User:
Start: 10/31/04 End: 12/31/05 Due: 12/31/06

A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications

Phase: N/A Priority: Normal
NCT ID: NCT04877288 Org: User:
Start: 07/21/21 End: 12/30/31 Due: 12/30/32